This is a multi-center, randomized, sham injection-controlled (placebo) masked trial of a
single intramuscular injection of Stannsoporfin compared to "sham" (placebo) in healthy term
and near-term newborns admitted to the well-baby nursery and enrolled with "intention to
treat".
Phase:
Phase 3
Details
Lead Sponsor:
InfaCare Pharmaceuticals Corporation InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company